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Pemphigus is a chronic mucocutaneous autoimmune bullous disease that is characterized by loss of cell-cell contact in skin
and/or mucous membranes. Past research has successfully identiﬁed desmosomes as immunological targets and has demonstrated
that acantholysis is initiated through direct binding of IgG. The exact mechanisms of acantholysis, however, are still missing.
Experimental model systems have contributed considerably to today’s knowledge and are still a favourite tool of research. In this
paper we will describe to what extent human cell and tissue models represent the in vivo situation, for example, organ cultures
of human skin, keratinocyte cultures, and human skin grafted on mice and, furthermore, how suitable they are to study the
pathogenesis of pemphigus. Organ cultures closely mimic the architecture of the epidermis but are less suitable to answer posed
biochemical questions. Cultured keratinocyte monolayers are convenient in this respect, but their desmosomal make-up in terms
of adhesion molecules does not exactly reﬂect the in vivo situation. Reconstituted skin is a relatively new model that approaches
organ culture. In models of human skin grafted on mice, acantholysis can be studied in actual human skin but now with all the
advantages of an animal model.
1.Introduction
Pemphigus is a chronic mucocutaneous autoimmune bul-
lous disease, characterized by the presence of autoantibodies
against the desmosomal cadherins, desmoglein 1 (Dsg1),
and/or desmoglein 3 (Dsg3). There are two main forms
of pemphigus: pemphigus foliaceus (PF) and pemphigus
vulgaris (PV). PF presents as superﬁcial blistering of the skin
and the presence of autoantibodies against Dsg1. In the case
of mucosal dominant PV, patients have suprabasal blistering
of the mucous membranes and auto-antibodies against
Dsg3 only. Patients with mucocutaneous PV have suprabasal
blistering of both the skin and the mucous membranes, in
combination with autoantibodies against both Dsg1 and 3.
Since the discovery by Beutner and Jordon in the
sixties, who demonstrated by indirect immunoﬂuorescence
(IIF) microscopy that sera of pemphigus vulgaris patients
contained IgG antibodies directed against a substance on
the surface of keratinocytes [1], investigators have tried to
answeranintriguingquestion:howdotheseantibodiescause
acantholysisinskin?Inthenineties,Mahoneyetal.presented
their theories on steric hindrance and desmoglein com-
pensation [2] as an explanation for acantholysis. Recently,
researchers are also focusing on other putative mechanisms
for example, cell signalling [3, 4], apoptosis [5], desmosome
assembly and disassembly [6], and endocytosis [7].
Although the exact steps in the process of acantholysis
in pemphigus are still not clear, research herein has consid-
erably beneﬁtted from experimental models, for example,
mouse models and in vitro models. Unlike the animal
models, the in vitro models have been used to study
the eﬀector-phase of pemphigus and not its cell-mediated
immune regulation. In this paper we will discuss the in vitro
models and focus on human cell and tissue models. These
models comprise organ cultures of human skin, cultured
human monolayer keratinocytes, reconstituted skin, and
human skin grafted on mice. We will discuss how well these
human cell and tissue models represent the in vivo situation
in human skin and their suitability to study the pathogenesis
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Figure 1: Incubation of normal human skin with pemphigus IgG or Fab fragments leads to suprabasal or subcorneal acantholytic blistering.
(a) Normal human skin (NHS) before incubation. Incubation of NHS for 24 hours in (b) medium only or in medium with added (c)
control Fab fragments or (e) control IgG leads to limited spongiosis of the epidermis. Incubation of NHS in medium with added (d) PF Fab
fragments and (f) PF IgG induces a subcorneal split. Incubation of NHS in medium with (g) PV IgG induces suprabasal acantholysis.
2.OrganCulturesofHumanSkin
Michel and Ko were among the ﬁrst who successfully pro-
duced acantholysis in vitro by using an organ culture model
[8]. They described a relatively simple and reproducible
method based on the work of Sarkany et al. [9]. Michel
et al. placed a skin explant on lens paper which ﬂoated
on the surface of liquid that contained crude pemphigus
serum. Since then, more research groups have used this
organ culture model to study pemphigus [10–18]. We
ourselves have recently performed experiments using an
organ culture model with air-liquid interface in which a
biopsy of normal human skin is not ﬂoated on lens paper
but instead placed on a transwell such that the bottom of
the biopsy contacts the solution containing IgG (Figure 1).
In a second approach we submerged biopsies in solution.
This enabled culturing more biopsies in one and the same
volume of medium with added pemphigus IgG or Fab
fragments. Biopsies can be easily harvested at any time
and processed for light microscopy, immunoﬂuorescence, or
electron microscopy. Although submerged culturing induces






























in medium for 72 hours, Dsg1 expression is reduced. (d) Dsc1 is expressed in the upper layers of the epidermis. (e) The expression of Dsc1
by skin incubated in medium for 24 hours is comparable to that of NHS. (f) After incubation in medium for 72 hours, Dsc1 expression is
reduced. (g) Dsg3 is expressed in the basal and suprabasal layers of the epidermis in NHS. (h) The expression of Dsg3 after incubation in
medium for 24 hours is comparable to that of NHS. (i) After incubation in medium for 72 hours, Dsg3 is also expressed in the upper layers
of the epidermis.
example, substantial loss of Dsg1 and desmocollin 1 (Dsc1)
with increased expression of Dsg3 in higher cell layers,
this only manifests after prolonged culturing, and their
expression remains comparable to normal human skin when
the experiments are limited to 24 hours (Figure 2).
Michel and Ko incubated normal human skin with
undiluted sera from pemphigus patients. Direct immunoﬂu-
orescence (DIF) showed intercellular staining of IgG. Light
microscopy showed a split after 24-hours incubation. Unfor-
tunately, this ﬁrst attempt was not as successful as had been4 Dermatology Research and Practice
hoped and both PF and PV sera induced a suprabasal split
[8]. Later investigators, however, did succeed in producing
correct subcorneal splits in normal human skin with PF
IgG [16]. In our own organ culture model subcorneal
acantholysis can be induced not only by PF IgG but also by
PF Fab fragments (Figure 1(f)).
Next to whole serum, Michel and Ko also performed
incubations with heated serum in order to inactivate
complement [8]. Heated serum also led to acantholysis,
which showed that the pathogenesis of pemphigus was not
complement dependent [8, 19, 20]. The demonstration that
Fab fragments of pemphigus IgG also induce acantholysis
conﬁrmed the concept that complement ﬁxation was not
a necessary step in this disease [21]. Acantholysis thus is
independent of IgG subclass.
Hu et al. studied the eﬀects of pemphigus IgG incuba-
tion on normal human skin by electron microscopy [22].
After 12-hours incubation the ﬁrst changes, for example,
intercellular widening, were seen. After 24 hours the inter-
cellular widening had progressed, and dissolution of the
desmosomes became visible. Also desmosome remnants
could be seen on the surfaces of the keratinocytes; the
tonoﬁlamentshad retracted from the cellperiphery and were
concentrated in a perinuclear position. After 72 hours a
suprabasal split and widening between the basal cells (a row
of tombstones) were seen [22]. Most of the observations
described by Hu et al. are comparable to those seen in
pemphigus patient skin, but whether or not the observed
retraction of tonoﬁlaments in this organ culture model is
comparable to the in vivo situation remains a matter of
debate. Unlike others [23], we ourselves did not observe
this retraction of tonoﬁlaments in pemphigus patient skin
[24].
The human organ culture model has been very valuable
in obtaining information on the mechanisms of acan-
tholysis and, moreover, has also been used to test old
and new therapeutic drugs for pemphigus, for example,
hydrocortisone[13],dapsone[13],methylprednisolone[17],
and protease inhibitors [15]. Although most popular in
the eighties, it is still used today, often in combination
with other models [16, 25–28]. The major advantage of
skin explants remains that it is actual human skin with
correct architecture of all epidermis layers. Layer-speciﬁc
changes in morphology or protein localization can easily
be studied by light microscopy, immunoﬂuorescence, or
electron microscopy. However, explants are less suitable
to answer biochemical questions concerning molecular
pathways, that is, the activation of receptor molecules or
changes in phosphorylation state of pathway intermediates.
In contrast to cultured cells, cells in the skin explant reside
in layers of varied diﬀerentiation that most likely respond
diﬀerently to external stimuli. Aside from this, cultured
cells will instantaneously make contact with the added
IgG, while in organ cultures the IgG must diﬀuse into
the epidermis and will not reach all cells simultaneously.
Therefore, more easily manageable culture models are the
preferred models for biochemical and molecular biological
research on acantholysis.
3.KeratinocyteCultures
A year after the ﬁrst publication on the organ culture model,
Schiltz et al. incubated human keratinocytes with pemphi-
gus IgG [29]. The results of these experiments suggested
that binding of pemphigus antibodies to the keratinocytes
initiates a series of events which result in the release or
activation of hydrolytic enzymes by the keratinocytes with
subsequentautolysisandacantholysis.Thismadeitclearthat
keratinocyte cultures could serve as a model for acantholysis.
Various sources of cells are now being used, with most
researchers using normal human epidermal keratinocytes
(NHEKs) [30–32]. These keratinocytes are often derived
from neonatal foreskin [6, 7, 28, 33–37] but can also be
obtained from surgical excised skin [38]. HaCaT cells, a non-
tumorigenic human keratinocyte cell line, are also popular
[16, 39–43]. Less commonly used is the squamous cell
carcinoma (SCC) cell line DJM-1 [35, 44].
Cultured keratinocytes are mostly used as monolayers
or alternatively as reconstituted skin. Keratinocytes grown
in low calcium medium will proliferate until conﬂuent and
then become growth arrested. In high-calcium medium
(1.2mMorhigher)cellswilldiﬀerentiate,formdesmosomes,
and stratify [45]. For reconstituted skin, it is a requisite
to culture the keratinocytes on a dermal equivalent [46].
Varying the calcium concentration provides a tool to induce
and study desmosome assembly and disassembly [6, 45].
Whether cultured keratinocytes are a reliable model, to study
pemphigus pathogenesis, be it in the form of monolayers
or reconstituted skin, will depend mainly on their ability to
formmaturedesmosomeswithcorrectmake-upofcadherins
and associated molecules. The expression and localization
of the pemphigus antigens and other desmosomal adhesion
molecules in cultured cells, therefore, became an early
subject of research.
By IIF staining with patient sera it was shown that the PV
antigen is expressed in human epidermal monolayers when
cultured under high-calcium conditions, but at the same
time these monolayers lack the PF antigen [47].
Low-calcium cultured monolayer cells do not express
Dsg1 [47, 48] and Dsg2 [48], while high-calcium cultured
monolayers express Dsg1 [47]. As shown by immunoblot,
Dsg1 is detectable after 1 to 6 days of culturing [48], but
the expression levels appear to be low [33]. As keratinocytes
become stratiﬁed, Dsg1 expression increases and can be
detected on the plasma membrane of stratiﬁed cells in a
membrane-bound pattern [47]. The Dsg2 expression in
high-calcium cultured monolayers is only positive after
5-6 days as shown by immunoblot [48]. Some groups
report that the immunoblot does not show expression of
Dsg3 by low-calcium cultured monolayers [48]. Dsg3 was
detected in the cytoplasm of cells grown under low-calcium
conditions while the protein is translocated to the plasma
membrane when cultured under high-calcium conditions
[6]. Staining of desmocollin 3 (Dsc3) in NHEKs cultured
under low-calcium conditions shows a diﬀuse cytoplasmic
and a focal desmosomal pattern, but comparable to Dsg3
the desmosomal staining intensiﬁes after raising the calcium
concentration [6].Dermatology Research and Practice 5
Table 1: Expression of desmosomal components by monolayers composed of diﬀerent cell types cultured in low- or high-calcium medium.
−: negative, ±: weak positive, +: positive.
Low calcium High calcium
Cell type Dsg1 Dsg2 Dsg3 Dsc3 Dsg1 Dsg2 Dsg3 Dsc3
NHEK −−−+ ± +++
HaCaT − ++ +++
SCC −−− +++
HaCaT cells are capable of expressing Dsg1, Dsg2, and
Dsg3 [43, 48], and similar to normal keratinocytes, Dsg1
expression is induced by high levels of calcium [48].
Most tested SCC cell lines have weak or focal intercellular
expression of PV antigens and expression of PF antigens in
localized areas [47]. Denning et al. tested several SCC cell
lines and showed by immunoblot Dsg2 and Dsg3 expression
by these cells when cultured in normal or high-calcium
media [48]. Aoyama and Kitajima used the DJM-1 cell line
and showed expression of Dsg1 and Dsg3 when cultured in
high calcium [49].
From the information summarized in Table 1,w ec a n
conclude that NHEKs have limitations as an experimental
model for pemphigus since these cells do not express
signiﬁcant amounts of Dsg1. Consequently, these experi-
mental systems are not suitable to study acantholysis in
PF and mucocutaneous PV. HaCaT cells and DJM-1 cells
(Table 1), which express Dsg1 in monolayers, might be more
appropriate model systems. It must be taken into account,
however, that these cells might express Dsg2 [50] that is not
present in most skin areas aﬀected by pemphigus. Despite
all drawbacks, monolayers have contributed much to our
knowledge on acantholysis and have been at the basis of
new ideas and insights. An elegant practical example of their
use is the in vitro keratinocyte dissociation assay that can
quantify the anti-Dsg3 acantholytic eﬀects of patient IgG
[7, 32, 33, 42, 44, 51–53]. After incubation of monolayers
with IgG, dispase is used to release the cell sheet from the
culture dish. This sheet is then subjected to ﬁerce mechanical
stress by means of pumping in and out of a syringe. The
resulting number of cell fragments is a quantiﬁcation of the
acantholyticeﬀectoftheIgG[54].Anillustrationofjusthow
important the cadherin composition of the desmosomes is
becomes apparent when HaCaT cells are used in the same
assay and no fragments are formed. This is likely due to the
high Dsg2 expression [54].
Keratinocytes cultured in reconstituted skin will diﬀer-
entiate and stratify. Therefore both PV and PF antigens are
expressed in reconstituted skin [47, 55–57]. By culturing
keratinocytes air-exposed on a dermal equivalent, it is
possible to reconstruct a multilayered epidermis [46, 58].
The morphology of this reconstituted skin can be compared
to that of epidermis in vivo [46, 58, 59]. Ultrastructural
assessment of a skin equivalent showed mature desmosome
formation [46, 59]. Unfortunately, the expression of the
desmosomal proteins, the cadherin antigens, and the forma-
tion of desmosomes in these skin equivalents are not well
documented. DIF or IIF of desmosomes showed intercellular
staining, but in contrast to human skin, there is also strong
staining at the top level or corniﬁed layer [58, 59]. Few
researchers used reconstituted skin as an in vitro model to
study the pathogenesis of pemphigus [60–62].
4.H um anSkinG raft edo nM ic e
As mentioned in the introduction, mouse models are often
used in pemphigus research next to the human in vitro
models. By using mouse models, however, pemphigus is
induced in murine skin which might diﬀer in its function
from human skin. By grafting human skin on mice, acan-
tholysis can be studied in human skin while at the same
timeprovidingtheresearcherwiththeadvantagesofamouse
model [63]. There is only limited experience with these
mouse models in pemphigus. Zillikens et al. grafted full-
thickness human skin onto the back of SCID mice [64].
PF and PV IgG were injected in the dermis of the graft.
Histopathologic ﬁndings and DIF of the grafted human skin
were comparable to histopathologic ﬁndings and DIF in PF
and PV patient skin. Others used reconstituted skin grafted
onto SCID mice, and subcorneal blistering was induced by
injection of PF IgG [27]. These graft models therefore seem
very promising.
5. Model Comparison
When studying a human disease, a model is required
that approaches the in vivo human situation as closely
as possible. Studying the pathogenesis of pemphigus in
patientsunfortunatelyhasitslimitations.Forethicalreasons,
biopsies cannot be taken too often making it impossible
to in detail follow the time course of disease development.
Mouse models have given great insight into the disease,
but mice are not completely comparable to humans, so
some questions remain that will have to be addressed in
human models. The human in vitro models described in
this paper all have their advantages and disadvantages.
Therefore no single model may be preferred, but diﬀerent
models may be used in a complementary fashion. Organ
cultures and skin equivalents have the advantage that they
are most comparable to human skin in terms of desmoglein
expression and mature desmosomes. Acantholysis can be
evaluated easily with light microscopy, immunoﬂuorescence
or electron microscopy. To study pathways and to follow the
fate of individual molecules in a narrow time frame in terms
of expression level, shifts in localization, phosphorylation,
or molecular interaction, easily manageable culture models
are favoured. Cell lines should be chosen such that they6 Dermatology Research and Practice
reﬂect the skin situation as closely as possible. As discussed
before they are suitable to study aspects of acantholysis in
PV but not PF for the simple reason that no cells so far
have been cultured that express Dgs1 in absence of Dsg3.
The mechanism of pemphigus acantholysis has been studied
for the past forty years and has taught us which molecules
are involved and that acantholysis occurs in the absence of
inﬂammation mediators. How desmosomes split and what
molecularpathwaysleadtoacantholysisisstillbeingdebated.
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